| Primary |
| Drug Use For Unknown Indication |
54.8% |
| Chronic Obstructive Pulmonary Disease |
19.4% |
| Asthma |
12.9% |
| Gastric Ulcer |
3.2% |
| Hypertension |
3.2% |
| Smoking Cessation Therapy |
3.2% |
| Urinary Tract Infection |
3.2% |
|
| Tremor |
33.3% |
| Heart Rate Increased |
16.7% |
| Oedema Peripheral |
16.7% |
| Toxicologic Test Abnormal |
16.7% |
| Urinary Tract Infection |
16.7% |
|
| Secondary |
| Asthma |
17.0% |
| Drug Use For Unknown Indication |
17.0% |
| Emphysema |
14.1% |
| Atrial Fibrillation |
7.8% |
| Depression |
7.4% |
| Product Used For Unknown Indication |
7.4% |
| Arrhythmia |
3.5% |
| Duodenal Ulcer |
3.2% |
| Cardiac Failure Chronic |
2.5% |
| Gastrointestinal Haemorrhage |
2.5% |
| Hypertension |
2.5% |
| Spinal Compression Fracture |
2.1% |
| Bronchitis |
1.8% |
| Cholelithiasis |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
1.8% |
| Pneumonia |
1.8% |
| Cardiac Failure Congestive |
1.4% |
| Gastric Cancer |
1.4% |
| Neuralgia |
1.4% |
|
| Tonic Convulsion |
12.0% |
| Antasthmatic Drug Level Above Therapeutic |
8.0% |
| Polymyositis |
8.0% |
| Tachycardia |
8.0% |
| Toxicologic Test Abnormal |
8.0% |
| Neuroleptic Malignant Syndrome |
6.0% |
| Vasculitis |
6.0% |
| Drug Eruption |
4.0% |
| Eosinophilic Pneumonia |
4.0% |
| Erythema Multiforme |
4.0% |
| Interstitial Lung Disease |
4.0% |
| Pyrexia |
4.0% |
| Rhabdomyolysis |
4.0% |
| Sepsis |
4.0% |
| Tubulointerstitial Nephritis |
4.0% |
| Vomiting |
4.0% |
| Anaemia |
2.0% |
| Death |
2.0% |
| Hepatic Function Abnormal |
2.0% |
| Hypertension |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Asthma |
23.1% |
| Drug Use For Unknown Indication |
19.3% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Hypertension |
3.4% |
| Emphysema |
2.7% |
| Pain |
2.5% |
| Prophylaxis |
1.9% |
| Rhinitis Allergic |
1.6% |
| Depression |
1.2% |
| Hypersensitivity |
1.2% |
| Insomnia |
1.1% |
| Bronchitis |
0.9% |
| Rheumatoid Arthritis |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Diabetes Mellitus |
0.6% |
| Herpes Zoster |
0.6% |
| Osteoporosis |
0.6% |
| Arthritis |
0.5% |
| Constipation |
0.5% |
|
| Asthma |
11.6% |
| Dyspnoea |
8.2% |
| Pyrexia |
6.9% |
| Pneumonia |
6.4% |
| Vomiting |
6.4% |
| Urticaria |
6.0% |
| Wheezing |
5.6% |
| Status Asthmaticus |
5.2% |
| Allergic Granulomatous Angiitis |
4.7% |
| Weight Decreased |
4.7% |
| Nasopharyngitis |
4.3% |
| Death |
3.9% |
| Myocardial Infarction |
3.9% |
| Renal Failure Acute |
3.4% |
| Somnolence |
3.4% |
| Stillbirth |
3.4% |
| Loss Of Consciousness |
3.0% |
| Nausea |
3.0% |
| Rhabdomyolysis |
3.0% |
| White Blood Cell Count Increased |
3.0% |
|
| Interacting |
| Asthma |
65.2% |
| Smoking Cessation Therapy |
17.4% |
| Pain |
8.7% |
| Ex-smoker |
4.3% |
| Trigeminal Neuralgia |
4.3% |
|
| Oedema Peripheral |
50.0% |
| Dyspnoea |
16.7% |
| Social Avoidant Behaviour |
16.7% |
| Wheezing |
16.7% |
|
